A total of 85 blood samples from 17 patients with at least three blood collections (n = 3–9) and two measurements of serum AFP levels (n = 2–8) were analyzed for investigating whether or not CTC counts are suitable for disease monitoring of patients with advanced or metastatic HCC. Here, AFP is linked to hepatocellular carcinoma.